Global Gene Editing Technologies Market Report 2023: Sector is Expected to Reach $16.37 Billion by 2032 at a CAGR of 27.5%
30 mai 2023 06h08 HE
|
Research and Markets
Dublin, May 30, 2023 (GLOBE NEWSWIRE) -- The "Gene Editing Technologies Market - A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Region - Analysis and...
Gene Editing Global Market Report 2023: Rising Infectious Diseases Fuel the Sector
12 mai 2023 10h03 HE
|
Research and Markets
Dublin, May 12, 2023 (GLOBE NEWSWIRE) -- The "Gene Editing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and...
Intellia Therapeutics Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
04 mai 2023 07h30 HE
|
Intellia Therapeutics, Inc.
Dosed first patient in the global Phase 2 study of NTLA-2002 for the treatment of hereditary angioedema (HAE)Expects to complete enrollment in the Phase 2 study of NTLA-2002 in 2H 2023Plans to submit...
Macomics Presents its ENIGMAC™ Discovery Platform for Gene to Function Target Validation of Novel Macrophage Therapies at AACR
17 avr. 2023 13h30 HE
|
Macomics Limited
EDINBURGH, United Kingdom and CAMBRIDGE, United Kingdom, April 17, 2023 (GLOBE NEWSWIRE) -- Macomics Ltd, a leader in macrophage drug discovery has presented data demonstrating the power of its...
United Kingdom Cell & Gene Therapy Business and Investment Opportunities Databook - Q1 2023 Update
14 avr. 2023 07h33 HE
|
Research and Markets
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "United Kingdom Cell & Gene Therapy Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ...
Transfection Reagents and Equipment Global Market Report 2023: Growing Demand for Synthetic Genes Fuels Sector
21 mars 2023 06h53 HE
|
Research and Markets
Dublin, March 21, 2023 (GLOBE NEWSWIRE) -- The "Transfection Reagents and Equipment Market by Product, by Method, by Application, by End User, and by Region - Global Forecast to 2022-2033" report...
Intellia Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for NTLA-2002, an In Vivo CRISPR-Based Investigational Therapy for the Treatment of Hereditary Angioedema (HAE)
02 mars 2023 07h00 HE
|
Intellia Therapeutics, Inc.
CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapies...
Global Cell & Gene Therapy Business and Investment Opportunities Q1 2023 Update: Mergers and Acquisitions Continue to Dominate Growth Prospects
24 févr. 2023 08h53 HE
|
Research and Markets
Dublin, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The "Global Cell & Gene Therapy Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial...
Global Gene Editing Technology Market Report 2023 Featuring bluebird, Beam, Caribou Bio, Cellectis, Allogene, Intellia TX, Editas Medicine, Verve, AstraZeneca, Merck, & Thermo Fisher Scientific
21 févr. 2023 11h43 HE
|
Research and Markets
Dublin, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The "Global Gene Editing Technology Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial...
Gene Therapy Global Market Report 2023: Increasing Prevalence of Cancer Fuels Demand
16 févr. 2023 08h53 HE
|
Research and Markets
Dublin, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type...